Gain of Chromosome 1q is Associated with Early Progression in Multiple Myeloma Patients Treated with Lenalidomide, Bortezomib, and Dexamethasone

Using deep learning methods to predict the VRC01 neutralization sensitivity by HIV-1 gp160 sequence features